Ashish C. Bhatia MD, FAAD
Associate Professor of Clinical Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Co-Founder, Director of Clinical Research, and Co-Director, Dermatologic, Laser and Cosmetic Surgery, Oak Dermatology, Itasca, Joliet, and Naperville, IllinoisDr. Ashish Bhatia is a board-certified and fellowship-trained dermatologist and dermatologic surgeon. He is an Associate Professor of Clinical Dermatology at Northwestern University Feinberg School of Medicine in Chicago and the Director of Dermatologic, Laser, and Cosmetic Surgery at Oak Dermatology (locations in Itasca, Joliet, and Naperville, Illinois).
Dr. Bhatia is a recognized expert in dermatologic surgery and cosmetic surgery. His clinical expertise includes Mohs and reconstructive surgery, skin cancer therapy and prevention, laser surgery, skin resurfacing procedures, and cosmetic procedures including lasers, fillers, and neuromodulators. He also has a special interest in restorative procedures for adults and children with burns, surgical scars, and traumatic scars.
After receiving his medical degree from Northeastern Ohio University College of Medicine, Dr. Bhatia completed his residency in dermatology at the Medical College of Virginia Hospitals, where he served as Chief Resident. Subsequently, he completed an intensive fellowship in Mohs surgery, cutaneous oncology, and reconstruction, cosmetic, and laser surgery at SkinCare Physicians in Boston, Massachusetts.
Disclosures
- Grants/research: AbbVie; Alastin Skincare; Avita Medical; Cutera; Medline; NovaScan; Pulse Biosciences; R2 Technologies; Revance
- Consulting/advisory boards: Alastin Skincare; Allergan/AbbVie; Arcutis; Avita Medical; Bausch Health; Carpe; Cutera; Cytrellis; Emblation Ltd; Endo Aesthetics; Entrepix Medical; Evolus; Medline; MiMEDx; Obagi; Ortho Dermatologics; RBC Consultants; Revance; Solta; Sofwave; Strata Skin Sciences; Theravant Corp
- Speaker bureau: Allergan; Cutera; DermEd Foundation; Evolus; Medline; MiMEDx; Ortho Dermatologics; Paradigm Medical; Revance; Theravant Corp
- Ownership interest/shareholder: Biomarck; Carpe; Cutera; Derma MD; Genzum; SimSkin; Sonoma; Theravant Corp; Zalea
- Stock/options: AbbVie; Bausch Health; Biomarck; Carpe; Cutera; Cytrellis; Strata Skin Health
- Executive role/board member: Theravant Corp; DermEd Foundation
Recent Contributions to PracticeUpdate:
- Non-Sterile Gloves Safe for Resection and Reconstruction During Mohs Surgery
- Efficacy and Safety of Different Doses of Dutasteride for Male Androgenetic Alopecia
- 2013 Top Stories in Dermatology: Dermatologic Surgery
- Sclerotherapy as an Option for Digital Mucous Cysts
- Increased Incidence of Lentigo Maligna From 1970 to 2007
- Long-Term Safety of AbobotulinumtoxinA for Glabellar Lines
- Pulsed Dye Laser Using Purpuric vs Nonpurpuric Parameters for Surgical Scars
- Primary Skin Cancer Incidence Increased After Organ Transplantation
- Q-Switched Laser Depigmentation in Vitiligo Most Effective in Active Disease
- Regression Associated With Favorable Outcomes in Stage I/II Melanoma